17% ALK Mutation Detected in Lung Adenocarcinoma Genetic Testing, Should Targeted Therapy Continue After One Month of Crizotinib Use and NegativeALK?
For patients with ALK-positive non-small cell lung cancer, targeted therapy is the preferred treatment. However, even if ALK turns negative, it may still be considered to continue using targeted drugs, depending on the patient’s specific condition and doctor’s advice.
One minute to read